Literature DB >> 3750374

Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.

T B Vree, T J Janssen, Y A Hekster, E F Termond, A C van de Dries, W J Wijnands.   

Abstract

In five cases of carbamazepine (CBZ) intoxication, the time curves of the plasma concentration and of the renal excretion rate of carbamazepine and its metabolites carbamazepine 10,11-epoxide (CBZ-epoxide) and trans-10,11-dihydro-10,11-dihydroxy-CBZ (CBZ-diol) were measured. Pseudo-steady-state or plateau-like plasma concentration-time curves were observed when doses of 12 or 18 g of CBZ were ingested. Hemoperfusion lowers the plasma concentration of CBZ and its metabolites by affecting the half-life. The effect of hemoperfusion is reduced by the continuous absorption from the gastrointestinal tract and redistribution from the tissues. The renal clearances of CBZ and of CBZ-epoxide are low (1 and 8 ml/min, respectively); both are flow dependent. The renal clearance of CBZ-diol is approximately 160-350 ml/min and is independent of the urine flow. Although urine stimulation increases the renal clearance of CBZ by 100%, the overall amount excreted increases only 1-2% of the dose. Protein binding of CBZ is approximately 80%, of CBZ-epoxide 50%, and of CBZ-diol 70%.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3750374     DOI: 10.1097/00007691-198609000-00011

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  8 in total

Review 1.  Pharmacokinetics of drugs in overdose.

Authors:  Y J Sue; M Shannon
Journal:  Clin Pharmacokinet       Date:  1992-08       Impact factor: 6.447

2.  Successful treatment of severe carbamazepine toxicity with 5% albumin-enhanced continuous venovenous hemodialysis.

Authors:  Rajeev Narayan; Meagan Rizzo; Michael Cole
Journal:  J Artif Organs       Date:  2014-01-22       Impact factor: 1.731

Review 3.  Clinical toxicology.

Authors:  J A Vale
Journal:  Postgrad Med J       Date:  1993-01       Impact factor: 2.401

4.  Signs and symptoms of carbamazepine overdose.

Authors:  S Schmidt; M Schmitz-Buhl
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 5.  Pharmacokinetic optimisation of anticonvulsant therapy.

Authors:  A H Thomson; M J Brodie
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447

Review 6.  Controlled release drugs in overdose. Clinical considerations.

Authors:  N A Buckley; A H Dawson; D A Reith
Journal:  Drug Saf       Date:  1995-01       Impact factor: 5.606

Review 7.  Carbamazepine toxicity and poisoning. Incidence, clinical features and management.

Authors:  L Durelli; U Massazza; R Cavallo
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

Review 8.  Extracorporeal treatment for carbamazepine poisoning: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Marc Ghannoum; Christopher Yates; Tais F Galvao; Kevin M Sowinski; Thi Hai Vân Vo; Andrew Coogan; Sophie Gosselin; Valery Lavergne; Thomas D Nolin; Robert S Hoffman
Journal:  Clin Toxicol (Phila)       Date:  2014-10-30       Impact factor: 4.467

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.